Views

PIP is a lifeline for thousands of people living with HIV – it has to be protected.

A prescription model will help to stop new cases and alleviate the pressures faced by many women with HIV.

30% of sexual health services in rural England don’t offer this postal service

George Westwood writes that in 2022 we have continued working for HIV rights, with major victories: two big campaigns, a report which helped shift the conversation around PrEP, and pushing for reforms around mental health and migration.

This Black History Month, National AIDS Trust wishes to celebrate and champion the value of black leadership and representation to create impactful community change and address health inequality.

Scientific advances in HIV include the development of effective medications, self-tests, the discovery that people on effective treatment can’t pass HIV on, prevention tools and the emergence of long-acting injectable treatments.

Michelle, founder, Director of Holistic Wellbeing Services and training lead at CliniQ on why the barriers to PrEP access that are faced by trans people must be addressed.

Originally from Kenya, and a National AIDS Trust trustee, Angelina is experienced in providing one-to-one support, treatment advocacy, managing service delivery, and advocating for the involvement of women living with HIV in strategy and policy.

Jay Hawkridge is a HIV campaigner, a writer, vlogger and social media influencer who uses his platform to raise awareness about HIV and challenge stigma.

Marc Thompson is Director of The Love Tank; co-founder of PrEPster, and creator of the podcast We Were Always Here. He has been living with HIV since 1986.

To bring 2021 to a close, we've rounded up our highlights of the year. These successes wouldn't have been possible without your continued support, so we just want to say a big thank you to everyone who got involved with our work.

Dr Tristan Barber writes how last month, NICE approved the use of long-lasting injectable treatment for people living with HIV, the first alternative to daily oral pills. You can read our full blog on the announcement here.